[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.167.149.128. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Observation
January 2003

A Fatal Case of Coxsackievirus B4 Meningoencephalitis

Author Affiliations

From the Neurological Institute of New York, New York–Presbyterian Hospital, Columbia-Presbyterian Medical Center, New York, NY (Drs Cree, Hays, and Lowe), and Division of Stroke and Neurocritical Care, Department of Neurology, Albany Medical Center, Albany, NY (Dr Bernardini).

Arch Neurol. 2003;60(1):107-112. doi:10.1001/archneur.60.1.107
Abstract

Background  Coxsackieviruses and echoviruses are common causes of aseptic meningitis, but they rarely cause life-threatening illness. We report a fatal case of coxsackievirus B4 meningoencephalitis in a woman who developed extrapyramidal symptoms suggestive of encephalitis lethargica. The exact causative agent of encephalitis lethargica has rarely been found, but most cases of the syndrome are assumed to be of viral origin.

Case Description  A 33-year-old woman previously treated with methylprednisolone and cyclophosphamide for Henoch-Schönlein purpura was transferred from a referring hospital because of sore throat, fever, and chills. Her neurologic findings progressed from headache with mild photophobia to lethargy, cogwheeling, increased tone in all 4 limbs, and brisk reflexes. The patient was diagnosed as having coxsackievirus B4 meningoencephalitis and, despite treatment with the experimental antiviral agent pleconaril, died of an overwhelming central nervous system infection and myocarditis. Magnetic resonance imaging showed focal hyperintense lesions in the substantia nigra that corresponded to the location of pathological changes seen at autopsy.

Conclusions  This patient had a fulminant coxsackievirus B4 viral meningoencephalitis with a clinical pattern reminiscent of encephalitis lethargica and striking focal abnormalities in the substantia nigra identified on magnetic resonance imaging. The magnetic resonance imaging findings correlated with pathological changes identified at autopsy that were similar to the pathological findings observed in patients with encephalitis lethargica and postencephalitic parkinsonism. It is likely that the patient's immunocompromised state led to an overwhelming infection from an otherwise relatively innocuous viral infection.

APPROXIMATELY 20 000 cases of acute encephalitis are reported each year in the United States.1 In most cases, the causative infectious agent is viral, including Enteroviridae (eg, echovirus or coxsackievirus), arbovirus (eg, West Nile, eastern or western equine, St Louis, Venezuelan equine, California, or LaCrosse virus), Herpesviridae (eg, herpesvirus type 1 or 2, varicella-zoster virus, Epstein-Barr virus, and cytomegalovirus), and parvovirus, and can be identified from the cerebrospinal fluid (CSF) and/or blood.1 However, determination of the exact cause can be difficult, often requiring repeated CSF sampling and polymerase chain reaction amplification of the CSF. Abnormalities within the brain parenchyma (eg, medial temporal lobes or brainstem) seen on magnetic resonance (MR) imaging with T2- or T1-weighted images after gadolinium contrast injection can help to establish the diagnosis.

Coxsackievirus and echovirus are frequent causes of aseptic meningitis, particularly in children, but are rarely life threatening.26 We report a fatal case of meningoencephalitis and inflammatory myocarditis caused by coxsackievirus B4 likely owing to susceptibility in an individual with a pharmacologically induced state of immunosuppression.

REPORT OF A CASE

A 33-year-old woman was admitted to a community hospital because of 1 week of malaise, sore throat, subjective fever, chills, bilateral ear pain, and joint pain in her hands and feet. The patient had a history of Henoch-Schönlein purpura, juvenile rheumatoid arthritis treated with methylprednisolone and cyclophosphamide, and required hemodialysis for IgA nephropathy. On presentation, her temperature was 39.8°C and a 2/6 systolic murmur was heard at the left sternal border. Results of general physical and neurologic examination were normal. Routine complete blood cell count showed a white blood cell (WBC) count of 1.7 ×103/µL, with a differential count of 34% polymorphonuclear leukocytes (PMNs), 4% bands, 38% lymphocytes, and 24% monocytes; a hemoglobin level of 11.9 g/dL; and a platelet count of 262 × 103/µL. Results of serum chemistry studies were normal except for an elevated serum urea nitrogen level of 71 mg/dL (25.3 mmol/L) and creatinine level of 4.6 mg/dL (407 µmol/L), consistent with her chronic renal failure. She was treated with intravenous antibiotics, stress-dosed corticosteroids, and granulocyte colony-stimulating factor for empirical coverage of presumed bacterial infection in a setting of cyclophosphamide-induced leukopenia.

On the fourth hospital day, the patient developed a headache, mild photophobia, nuchal rigidity, and temperature of 40.0°C but was otherwise neurologically intact. A lumbar puncture was performed, yielding clear, colorless CSF with a protein level of 0.128 g/dL, glucose level of 68 mg/dL (3.8 mmol/L), red blood cell (RBC) count of 0.00014 ×106/µL, and WBC count of 0.079 ×103/µL, with a differential count of 86% PMNs and 14% lymphocytes (Table 1). An opening pressure was not recorded. The gram stain and cultures did not show any organisms, but antibiotic therapy was broadened for empirical treatment of suspected bacterial meningitis. The patient's neurologic findings worsened 2 days later when she became stuporous, responding only to painful stimuli. Brainstem reflexes remained intact, with semipurposeful withdrawal of all 4 limbs and symmetrically brisk reflexes. A noncontrast computed tomographic scan of the head was normal, and an electroencephalogram (EEG) showed diffuse slowing but no epileptiform activity. Repeated CSF sampling yielded a protein level of 0.115 g/dL, glucose level of 68 mg/dL (3.8 mmol/L), RBC count of 0.000009 ×106/µL, and WBC count of 0.021 ×103/µL, with continued polymorphonuclear pleocytosis: 79% PMNs and 21% lymphocytes (Table 1). Cryptococcal antigen was not detected, and no organisms were seen on gram stain.

Cerebrospinal Fluid Analysis
Cerebrospinal Fluid Analysis

During the next 2 weeks the patient's level of arousal fluctuated between coma and lethargy. Periods of intermittent tachypnea were observed. She had marked dysarthria and roving eye movements in the horizontal plane and could occasionally follow some commands with hand squeezing. There was marked increase in tone with cogwheel rigidity in upper extremities and hyperactive deep tendon reflexes; bilateral ankle clonus was noted but with equivocal Babinski signs. Follow-up CSF examination on the 17th hospital day yielded a protein level of 0.077 g/dL, glucose level of 78 mg/dL (4.3 mmol/L), RBC count of 0.000005 ×106/µL, and WBC count of 0.069 ×103/µL, but now a lymphocytic predominance was observed: 6% PMNs and 94% lymphocytes (Table 1). Serologic studies sent for antibodies to Rickettsia, parvovirus B19, and Brucella were negative; toxoplasmosis and Epstein-Barr virus antibody testing was positive for IgG but negative for IgM antibodies. Malaria organisms were not seen on blood smear, and multiple blood cultures yielded no growth. Polymerase chain reaction examination of CSF did not amplify DNA for herpesvirus 1 or 2, cytomegalovirus, Mycobacterium tuberculosis, or Borrelia burgdorferi. Cytologic examination of the CSF was negative. Thyroid function test results and complement levels were normal. Other imaging studies including single-photon emission computed tomography of the brain, cerebral MR angiography, and total-body indium scan were negative.

The patient was transferred to New York–Presbyterian Hospital, New York, NY, on the 22nd day after the initial hospitalization. She was afebrile and her neck was supple but she remained stuporous, responding only to noxious stimulation with withdrawal of the limbs. Brainstem reflexes were intact and deep tendon reflexes were brisk, with bilateral ankle clonus and equivocal plantar responses. Laboratory studies at our institution showed a serum WBC count elevated to 14.0 ×103/µL with a differential count of 92% PMNs, 6% lymphocytes, and 2% monocytes. The elevated WBC count was presumed to be partly a consequence of treatment with granulocyte colony-stimulating factor. The CSF examination showed an opening pressure of 190 cm H2O, protein level of 0.032 g/dL, glucose level of 68 mg/dL (3.8 mmol/L), RBC count of 0.0001 ×106/µL, and WBC count of 0.010 ×103/µL, with a differential count of 88% lymphocytes and 12% monocytes (Table 1). Repeat polymerase chain reaction studies of the CSF did not amplify DNA for herpesvirus 1 or 2, Epstein-Barr virus, or cytomegalovirus, and CSF cultures did not grow bacteria or acid-fast bacilli; the VDRL test was nonreactive. An MR image of the brain showed focal, linear, nonenhancing hyperintense lesions on T1- and T2-weighted images in the region of the substantia nigra (Figure 1, A and B). Subtle linear hyperintense lesions on T2-weighted images in the posterior limb of the right internal capsule and superior lateral aspect of the right thalamus were also identified (images not shown). An MR angiogram of the circle of Willis and neck vessels was normal.

A and B, Axial magnetic resonance images demonstrating bilateral, symmetric increased signal intensity within the substantia nigra. A, T1-weighted image. B, T2-weighted fast spin-echo image. C and D, Pathological sections. C, Midbrain lesions showing depigmentation and focal necrosis of the substantia nigra (arrow) (hematoxylin-eosin). D, Lesion within the substantia nigra containing many macrophages and small mineral deposits. These deposits are shown as thin spicules (arrowheads) and 1 aggregate (arrow) (hematoxylin-eosin).

A and B, Axial magnetic resonance images demonstrating bilateral, symmetric increased signal intensity within the substantia nigra. A, T1-weighted image. B, T2-weighted fast spin-echo image. C and D, Pathological sections. C, Midbrain lesions showing depigmentation and focal necrosis of the substantia nigra (arrow) (hematoxylin-eosin). D, Lesion within the substantia nigra containing many macrophages and small mineral deposits. These deposits are shown as thin spicules (arrowheads) and 1 aggregate (arrow) (hematoxylin-eosin).

Three days later, the patient became tachypneic with bilateral hand jerking. An EEG showed moderate diffuse background slowing and frequent runs of frontally predominant rhythmic delta waves consistent with seizure activity. Phenytoin and valproic acid were begun. She subsequently became comatose with sluggish brainstem reflexes and required intubation and mechanical ventilation. Continuous EEG monitoring in the neurologic intensive care unit showed generalized background slowing and frequent spike-and-wave activity. She was treated for nonconvulsive seizures and given a continuous midazolam infusion.

Approximately 1 week later an electrocardiogram showed conduction abnormalities. Cardiac enzyme testing showed an elevated creatine kinase level of 906 IU/L, with a 13.6% MB fraction. Transthoracic echocardiogram showed mild global hypokinesis with regional wall motion abnormalities. These results were interpreted as consistent with myocardial inflammation.

The viral cultures sent on CSF obtained at our institution yielded coxsackievirus B4 enterovirus. In addition, a rectal swab yielded coxsackievirus B4 enterovirus, suggesting actively shedding virus in our patient. A research laboratory (ViroPharma, Exton, Pa) was contacted and arrangements were made for compassionate use of pleconaril, an antipicornavirus agent.7,8 The patient received a 7-day course of pleconaril without overt side effects; however, she remained comatose. The patient's hospital course was further complicated by pneumonia, anasarca, thrombocytopenia, deep venous thrombosis, and gastrointestinal tract bleeding. Fifty-three days after the onset of symptoms, she developed a fatal ventricular fibrillation.

A complete autopsy was performed that showed grossly normal brain, spinal cord, and meninges except for depigmentation of the substantia nigra bilaterally. Microscopic examination showed necrosis of the substantia nigra with near-complete loss of pigmented neurons and numerous macrophages, some containing a typical appearance of melanin (Figure 1, C and D). Basophilic spicules with a beaded appearance were scattered throughout the lesions, consistent with mineralized material. Similar but smaller lesions were located symmetrically in the lateral and superior aspects of the tegmentum. There were also sparse microglial nodules in the thalamus, inferior olivary nucleus, dentate nucleus, and cerebellar cortex. In particular, the dentate nucleus of the cerebellum was hypercellular with astrocytosis and neuronal loss. The macrophages and microglia were accompanied by a few scattered lymphocytes. No neurofibrillary tangles were specifically identified. The remainder of the brain and spinal cord were histologically normal. Examination of the heart showed extensive active myocarditis with moderate dilated cardiomyopathy. Additional pathological findings included vascular congestion and macrophages in the lungs, a bone marrow embolus in a small pulmonary artery, and near–end-stage chronic nephropathy.

COMMENT

This is the first reported case, to our knowledge, of documented coxsackievirus B4 infection presenting as encephalitis lethargica; however, we are cautious about overinterpreting this finding. It seems unlikely that coxsackievirus B4 is a causative agent of von Economo disease, since outbreaks of coxsackievirus B4 meningitis are not associated with encephalitis lethargica. We believe that the unusual pattern of illness in our patient was due to preexisting immunosuppression resulting in enhanced susceptibility to severe viral infection. Nevertheless, this case extends the pattern of illness attributable to coxsackievirus B4 infection.

The anteceding prodrome with signs of meningismus, fluctuating level of consciousness, increased tone, extrapyramidal signs, and respiratory disorder seen in our patient are reminiscent of encephalitis lethargica. Rare sporadic cases of encephalitis that bear striking similarity to von Economo disease have been reported since the time of the epidemic of 1915 to 1930.917 Because the causative agent of von Economo disease was never isolated, clinical diagnostic criteria were developed to identify sporadic cases of encephalitis lethargica.14,18 Indeed, the presence of impaired level of consciousness, central respiratory disturbance, and rigidity observed in our patient with encephalitis fit the proposed diagnostic criteria for encephalitis lethargica.14 However, our patient did not experience ophthalmoplegia or oculogyric crises, nor was there observable sleep disorder and abnormal behaviors during the acute phase of illness that are characteristic of the von Economo somnolent-ophthalmoplegic type of encephalitis lethargica.14,1820

A diagnosis of encephalitis lethargica is based on clinical presentation, cerebrospinal findings, EEG, and pathological features. von Economo19 described 3 clinical forms of the disease: the most common, the somnolent-ophthalmoplegic form, begins with an influenzalike illness followed by drowsiness and confusion progressing to coma associated with external ophthalmoplegia, oculogyric crises, and nystagmus as early features; the other 2 forms are bradykinesia-cataplexy-mutism and hyperkinesis, the latter of which is associated with extreme motor restlessness, visual hallucinations, and dyskinesias. Clinical features considered major criteria supporting the diagnosis of encephalitis lethargica include an acute or subacute encephalitis associated with at least 3 of the following major criteria: signs of basal ganglia involvement, oculogyric crises, ophthalmoplegia, obsessive-compulsive behavior, akinetic mutism, central respiratory irregularities, or somnolence and/or sleep inversion.14 The CSF is frequently abnormal, with signs of meningeal irritation, ie, increased pressure and protein content and mild or moderate predominantly lymphocytic pleocytosis that can be seen in the early stages. The CSF glucose level is invariably normal, but oligoclonal band positivity has been reported.21 An EEG during the acute phase of the illness often shows diffuse unilateral or bilateral slowing in the delta or theta frequencies and focal sharp-wave activity.14 Pathological findings of von Economo disease typically consist of a nonhemorrhagic involvement of the gray matter, preferentially in the midbrain. Although the most severe involvement is usually isolated to the brainstem and basal ganglia, cerebral cortex and spinal cord can be affected as well.14,22 The pathological hallmark of the disease is cytoplasmic inclusions of neurofibrillary tangles within the substantia nigra, often associated with severe neuronal loss.22

The MR imaging studies in our patient showed unusual hyperintense signals on both T1- and T2-weighted imaging in the substantia nigra bilaterally (Figure 1, A and B). The basis for these signal changes is uncertain. However, pathological changes seen at autopsy correlate anatomically with the MR imaging findings. Thus, the T1- and T2 hyperintense signals on MR imaging seen in our patient may be due to tissue necrosis and mineralization of the lesions. Microhemorrhages could give rise to hyperintense T1- and T2-weighted signals, although there was no histological evidence to support this suggestion at autopsy. Identical MR imaging findings were recently reported in a case of encephalitis lethargica.17 In that report, both T1- and T2-weighted hyperintensity was also seen in the substantia nigra, and the patient survived the acute encephalitis but developed postencephalitic parkinsonism. No causative agent was identified.

The substantia nigra was selectively involved in our patient and is reminiscent of the pathological changes seen in cases of postinfectious parkinsonism and encephalitis lethargica.23,24 Although pathological involvement of the basal ganglia and thalamus frequently occurs in postencephalitic parkinsonism and encephalitis lethargica, these structures appear less frequently and severely affected than the preferential involvement of the substantia nigra. Indeed, pathological findings in our case are strikingly similar to those in 4 patients with postencephalitis parkinsonism reported by Bojinov,23 one of whom had died of concurrent myocarditis. In this patient a virus was isolated but not identified. It is possible that coxsackievirus B4 may be another causative agent of this syndrome, since, as in our case, viral infection of the central nervous system was associated with destruction of the substantia nigra. However, it is speculative to say whether our patient would have had delayed onset of parkinsonism had she survived.

While the coxsackievirus B4 might be implicated in the evolution of parkinsonian symptoms, it is less clear how it caused profound coma in our patient. The diffuse slowing seen on EEG and seizure activity suggest that cerebral cortex was affected by the meningoencephalitis. Similar observations were described in cases of postencephalitic parkinsonism.14,23 It is curious that there was no extensive injury to the reticular activating system or cerebral cortex that could account for the coma. The diffuse subcortical white-matter astrogliosis in a case of von Economo encephalitis lethargica and in another case of postencephalitic parkinsonism described by Elizan and Casals25 was not seen in our case. Perhaps these structures were involved earlier in the course of the infection and were no longer compromised at the time of the patient's death, or the viral infection produced diffuse cerebral dysfunction by mechanisms other than tissue destruction.

Although the causative agent of von Economo encephalitis was never identified,26 a viral agent is implicated by pathological study.25 Subsequently, several viruses have been causally linked to postencephalitic parkinsonism. The coxsackievirus B2 was implicated in 2 cases of postencephalitic parkinsonism.27,28 A few patients infected with Japanese encephalitis virus showed signs of parkinsonism, either early in the course of the illness or as a long-term sequela.29,30 Postencephalitic parkinsonism was also reported after an outbreak of western equine virus31 as well as measles32 and Mycoplasma33 infections. Why infections by these agents would cause parkinsonism is not clearly understood, but it is assumed that injury to the substantia nigra is likely the common mechanism.

It is unclear why our patient developed severe encephalitis from a virus that causes mild aseptic meningitis in adults.26,34 Nevertheless, fatal coxsackievirus infections are observed in infants and children2,3537 and in patients with agammaglobulinemia.3840 Enteroviral infection can be life-threatening in the setting of immunosuppression. We observed that our patient became infected by coxsackievirus while undergoing immunosuppressive treatment for Henoch-Schönlein purpura and IgA nephropathy. Therefore, it is likely that immune suppression or possibly abnormalities intrinsic to her immune system made the patient susceptible to a more fulminant course of infection. There are similarities in the pathological changes in our patient to those seen in infantile coxsackievirus encephalitis41,42 and the enteroviral chronic meningoencephalitis of agammaglobulinemia39; however, in our patient there was less lymphocytic infiltration. Furthermore, severe changes in the substantia nigra seen in our patient are not seen in infantile coxsackievirus encephalitis or the enteroviral chronic meningoencephalitis of agammaglobulinemia, which spare this nucleus. There are no reports of postencephalitic parkinsonism in infantile enteroviral meningoencephalitis or in agammaglobulinemia.

Newer treatments such as pleconaril7,8 may provide benefit in the treatment of life-threatening enteroviral infections.43 However, early identification of the causative agent is vital for potential effectiveness of these therapies. Repeated viral cultures of the oral mucosa, rectal mucosa, and CSF are recommended in all patients suspected of having meningoencephalitis, and serologic testing is now available for most enteroviruses. This latter method may be a more practical assay for detection of infection, since standard viral cultures require rapid delivery to a virology laboratory for incubation. Polymerase chain reaction–based assays on CSF may eventually replace these other methods of enteroviral detection.40

Back to top
Article Information

Corresponding author and reprints: Gary L. Bernardini, MD, PhD, Division of Stroke and Neurocritical Care, Department of Neurology, 47 New Scotland Ave, MC-70, Albany, NY 12208-3479 (e-mail: bernarg@mail.amc.edu).

Accepted for publication April 5, 2002.

Author contributions: Study concept and design (Drs Cree and Bernardini); acquisition of data (Drs Cree, Hays, and Bernardini); analysis and interpretation of data (Drs Cree, Bernardini, Hays, and Lowe); drafting of the manuscript (Drs Cree and Bernardini); critical revision of the manuscript for important intellectual content (Drs Cree, Hays, Bernadini, and Lowe); administrative, technical, or material support (Drs Cree, Bernardini, Hays, and Lowe); study supervision (Dr Bernardini).

References
1.
Tyler  KLMartin  JB Infectious Diseases of the Nervous System.  Philadelphia, Pa: FA Davis Co; 1993.
2.
Cherry  JD Enteroviruses: coxsackieviruses, echoviruses, and polioviruses.  In: Feigin  RD, Cherry  JD, eds. Textbook of Pediatric Infectious Diseases.4th ed. Philadelphia, Pa: WB Saunders Co; 1998:1787-1838.
3.
Artenstein  MSCadigan  FCBuescher  EL Clinical and epidemiological features of coxsackie group B virus infection. Ann Intern Med.1965;4:597-603.
4.
Moore  MKaplan  MKMcPhee  JBregman  DJKlein  SW Epidemiologic, clinical, and laboratory features of Coxsackie B1-B5 infections in the United States, 1970-79. Public Health Rep.1984;99:515-522.
5.
Strikas  RAAnderson  LJParker  RA Temporal and geographic patterns of isolates of nonpolio enterovirus in the United States, 1970-1983. J Infect Dis.1986;153:346-351.
6.
Pallansch  MA Coxsackie B epidemiology and public health concerns. Curr Top Microbiol Immunol.1997;223:13-30.
7.
Rotbart  HAO'Connell  JFMcKinlay  MA Treatment of human enterovirus infections. Antiviral Res.1998;38:1-14.
8.
Rogers  JMDiana  GDMcKinlay  MA Pleconaril: a broad spectrum antipicornaviral agent. Adv Exp Med Biol.1999;458:69-76.
9.
Bickerstaff  ERCloake  PCP Mesencephalitis and rhombencephalitis. BMJ.1951;14:77-81.
10.
Nielson  JM Complication of encephalitis of the von Economo type. Bull Los Angeles Neurol Soc.1953;18:84-90.
11.
Espir  MLBSpalding  JMK Three recent cases of encephalitis lethargica. BMJ.1956;19:1141-1144.
12.
Hunter  RJones  M Acute lethargica-type encephalitis. Lancet.1966;5:1023-1024.
13.
Clough  CGPlaitakis  AYahr  MD Oculogyric crises and parkinsonism: a case of recent onset. Arch Neurol.1983;40:36-37.
14.
Howard  RSLees  AJ Encephalitis lethargica: a report of four recent cases. Brain.1987;110:19-33.
15.
Picard  Fde Saint-Martin  ASalmon  EHirsch  EMarescaux  C Postencephalitic stereotyped involuntary movements responsive to L-dopa. Mov Disord.1996;11:567-570.
16.
Blunt  SBLane  RJMTurjanski  NPerkin  GD Clinical features and management of two cases of encephalitis lethargica. Mov Disord.1997;12:354-359.
17.
Kun  LNYian  SYHaur  LSTjia  H Bilateral substantia nigra changes on MRI in a patient with encephalitis lethargica. Neurology.1999;53:1860-1862.
18.
Rail  DSchotz  CSwash  M Post-encephalitic parkinsonism: current experiences. J Neurol Neurosurg Psychiatry.1981;44:670-676.
19.
von Economo  C Encephalitis Lethargica: Its Sequelae and Treatment. Newman  KD, trans. London, England: Oxford University Press; 1931.
20.
Duvoisin  RCYahr  MD Encephalitis and parkinsonism. Arch Neurol.1965;12:227-239.
21.
Williams  AHouff  SLees  ACalne  D Oligoclonal banding in the cerebrospinal fluid of patients with postencephalitic parkinsonism. J Neurol Neurosurg Psychiatry.1979;42:790-792.
22.
Hallervorden  J Anatomische Untersuchungen zur Pathogenes des postencephalitischen Parkinsonismus. Dtsch Z Nervenheilkd.1935;136:68-77.
23.
Bojinov  S Encephalitis with acute parkinsonian syndrome and bilateral inflammatory necrosis of the substantia nigra. J Neurol Sci.1971;12:383-415.
24.
McApline  D The pathology of the parkinsonian syndrome following encephalitis lethargica, with a note on the occurrence of calcification in this disease. Brain.1923;46:255-281.
25.
Elizan  TSCasals  J Astrogliosis in von Economo's and postencephalitic Parkinson's diseases supports probable viral etiology. J Neurol Sci.1991;105:131-134.
26.
Casals  JElizan  TSYahr  MD Postencephalitic parkinsonism: a review. J Neural Transm.1998;105:645-676.
27.
Walters  JH Postencephalitic Parkinson syndrome after meningoencephalitis due to coxsackie virus group B, type 2. N Engl J Med.1960;263:744-747.
28.
Poser  CMHuntley  CPoland  JD Para-encephalitic parkinsonism: report of an acute case due to coxsackie type B 2 and re-examination of the etiologic concepts of postencephalitic parkinsonism. Acta Neurol Scand.1969;45:199-215.
29.
Ishii  TMatsushita  MHamada  S Characteristic residual neuropathological features of Japanese B encephalitis. Acta Neuropathol.1977;38:181-186.
30.
Shoji  HWatanabe  MItoh  SKuwahara  HHattori  F Japanese encephalitis and parkinsonism. J Neurol.1993;240:59-60.
31.
Mulder  DWParrott  MThaler  M Sequelae of western equine encephalitis. Neurology.1951;1:318-327.
32.
Meyer  B Encephalitis after measles with severe parkinsonian rigidity: recovery. BMJ.1943;24:508.
33.
Al-Mateen  MGibbs  MDietrich  RMitchell  WGMenkes  JH Encephalitis lethargica–like illness in a girl with mycoplasma infection. Neurology.1988;38:1155-1158.
34.
Rotbart  HABrennan  PJFife  KH  et al Enterovirus meningitis in adults. Clin Infect Dis.1998;27:896-898.
35.
Javett  SNHeymann  SMundel  B  et al Myocarditis in the newborn infant: a study of an outbreak associated with coxsackie B virus infection in a maternity home in Johannesburg. J Pediatr.1956;48:1-22.
36.
Rapmund  GGauld  JRRogers  NGHolmes  GE Neonatal myocarditis and meningoencephalitis due to coxsackie virus group B, type 4. N Engl J Med.1959;260:819-821.
37.
Kaplan  MHKlein  SWMcPhee  JHarper  RG Group B coxsackie virus infections in infants younger than three months of age: a serious childhood illness. Rev Infect Dis.1983;5:1019-1032.
38.
Wilfert  CMBuckley  RHMohanakumar  T  et al Persistent and fatal central-nervous-system ECHOvirus infections in patients with agammaglobulinemia. N Engl J Med.1977;296:1485-1489.
39.
McKinney Jr  REKatz  SlWilfert  CM Chronic enteroviral meningoencephalitis in agammaglobulinemic patients. Rev Infect Dis.1987;9:334-356.
40.
Webster  ADRotbart  HAWarner  TRudge  PHyman  N Diagnosis of enterovirus brain disease in hypogammaglobulinemic patients by polymerase chain reaction. Clin Infect Dis.1993;17:657-661.
41.
Moosy  JGeer  JC Encephalomyelitis, myocarditis and adrenal cortical necrosis in coxsackie B3 virus infection. Arch Pathol Lab Med.1960;70:614-622.
42.
Estes  MLRorke  LB Liquefaction necrosis in coxsackie B encephalitis. Arch Pathol Lab Med.1986;110:1090-1092.
43.
Schmugge  MLauener  RBossart  W  et al Chronic enteroviral meningo-encephalitis in X-linked agammaglobulinaemia: favorable response to anti-enteroviral treatment. Eur J Pediatr.1999;158:1010-1011.
×